People: AstraZeneca PLC (AZN.L)
Mr. Pascal Soriot is Executive Director and Chief Executive Officer of AstraZeneca PLC. Mr. Pascal was appointed as a Director and CEO in October 2012. From 2010 to September 2012, he served as Chief Operating Officer of Roche AG’s pharmaceuticals division. Prior to that, he was CEO of Genentech, a biologics business, and led its successful merger with Roche. He joined the pharmaceutical industry in 1986 and has worked in senior management roles throughout the world in a number of major companies. He brings to AstraZeneca a significant breadth of experience in both established and emerging markets, strength of strategic thinking, a successful track record of managing change and putting strategy into operation, and the ability to lead a diverse organisation, having lived in Australia, Japan, the US and Europe. He is a doctor of veterinary medicine (École Nationale Vétérinaire d’Alfort, Maisons-Alfort) and holds an MBA from HEC, Paris.
|Total Annual Compensation, GBP||2,378,000|
|Restricted Stock Awards, GBP||--|
|Long-Term Incentive Plans, GBP||10,533,000|
|All Other, GBP||478,000|
|Fiscal Year Total, GBP||13,389,000|